Predictor screening based on the training sets for groups Biopsy‐based CD diagnosis and Anti‐TG2‐based CD diagnosis compared with Not CD identified 16 candidate genes for sample classification, and 14 of these were selected using the Best subsets method for discriminating between Biopsy‐based CD diagnosis and Not CD (Table 2). This evidence concerns the gene TGM2 and Cowden disease.